The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma
Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-...
Saved in:
Published in | Oral oncology Vol. 47; no. 11; pp. 1023 - 1031 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
01.11.2011
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 1368-8375 1879-0593 1879-0593 |
DOI | 10.1016/j.oraloncology.2011.07.019 |
Cover
Abstract | Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)–CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) (
p
=
0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC (
p
=
0.015) and a high PCNA index (
p
=
0.011). The
in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells (
p
<
0.05 and
p
<
0.01, respectively). In
in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively (
p
=
0.000 and
p
=
0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells. |
---|---|
AbstractList | Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)-CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) (p=0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC (p=0.015) and a high PCNA index (p=0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells (p<0.05 and p<0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively (p=0.000 and p=0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells.Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)-CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) (p=0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC (p=0.015) and a high PCNA index (p=0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells (p<0.05 and p<0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively (p=0.000 and p=0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells. Summary Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)–CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) ( p = 0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC ( p = 0.015) and a high PCNA index ( p = 0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells ( p < 0.05 and p < 0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively ( p = 0.000 and p = 0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells. Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)–CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) ( p = 0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC ( p = 0.015) and a high PCNA index ( p = 0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells ( p < 0.05 and p < 0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively ( p = 0.000 and p = 0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells. Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)-CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) (p=0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC (p=0.015) and a high PCNA index (p=0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells (p<0.05 and p<0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively (p=0.000 and p=0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells. |
Author | Yoon, Hye-Jung Lee, Jae-Il Hong, Seong-Doo Lee, Yoo-Jin Hong, Kyoung-Ok Hong, Ji-Soo Shin, Wui-Jung Hong, Sam-Pyo |
Author_xml | – sequence: 1 givenname: Hye-Jung surname: Yoon fullname: Yoon, Hye-Jung – sequence: 2 givenname: Ji-Soo surname: Hong fullname: Hong, Ji-Soo – sequence: 3 givenname: Wui-Jung surname: Shin fullname: Shin, Wui-Jung – sequence: 4 givenname: Yoo-Jin surname: Lee fullname: Lee, Yoo-Jin – sequence: 5 givenname: Kyoung-Ok surname: Hong fullname: Hong, Kyoung-Ok – sequence: 6 givenname: Jae-Il surname: Lee fullname: Lee, Jae-Il – sequence: 7 givenname: Sam-Pyo surname: Hong fullname: Hong, Sam-Pyo – sequence: 8 givenname: Seong-Doo surname: Hong fullname: Hong, Seong-Doo email: hongsd@snu.ac.kr |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25527580$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21824804$$D View this record in MEDLINE/PubMed |
BookMark | eNqNklur1DAUhYMc8Vz0L0gQxKfWnaZJGx9EHa9wwAePDz6FTLo7ZmyTOUkrzL83ZcYLB4R5SgjfXqystS_JmQ8eCXnCoGTA5PNtGaIZgrdhCJt9WQFjJTQlMHWPXLC2UQUIxc_yncu2aHkjzsllSlsAEEzAA3JesbaqW6gvyLeb70hjGJCGnq6i202hYNR5OuX3aR5DdBv0mFyixnd0F8MmYkou-GVg8UHT7WzGMCdqcRioNdE6H0bzkNzvzZDw0fG8Il_fv7tZfSyuP3_4tHp9XVjRiKkQtmpbYFXf8TVXkvdcIMtGu7rjkrVK9fUarbBYMdPZRpo1Slt3yHvFpJU1vyLPDrrZ2-2MadKjS4sV4zG70gpAVkpJmcnHR3Jej9jpXXSjiXv9O40MPD0CJlkz9NF469JfToiqES1k7sWBszGkFLH_gzDQS0V6q_-tSC8VaWh0rigPv7ozbN1kppzoFI0bTpN4e5DAnOtPh1En69Bb7FxEO-kuuNNkXt6RsYPzLv_8B-4xbcMcfW5OM50qDfrLsk7LNrHcTyOBZ4E3_xc41cUvSeziqg |
CitedBy_id | crossref_primary_10_2174_0929867325666180912104707 crossref_primary_10_1615_CritRevOncog_2022047207 crossref_primary_10_1002_jcb_29293 crossref_primary_10_1007_s13277_014_2695_1 crossref_primary_10_1097_MD_0000000000011781 crossref_primary_10_3390_ijms221810164 crossref_primary_10_1007_s00405_018_4960_1 crossref_primary_10_1007_s13277_014_2039_1 crossref_primary_10_1590_0001_3765202020200519 crossref_primary_10_1111_odi_13730 crossref_primary_10_7314_APJCP_2014_15_20_8549 crossref_primary_10_1016_j_toxrep_2019_05_013 crossref_primary_10_1007_s10006_020_00877_0 crossref_primary_10_1016_j_oraloncology_2018_11_001 crossref_primary_10_3390_cancers12061480 crossref_primary_10_1016_j_bjorl_2019_04_002 crossref_primary_10_1007_s12038_017_9700_y crossref_primary_10_3892_mmr_2016_5126 crossref_primary_10_18632_oncotarget_5057 crossref_primary_10_1111_crj_13680 crossref_primary_10_2217_bmm_2019_0159 crossref_primary_10_3389_fonc_2022_830873 crossref_primary_10_1593_tlo_13427 crossref_primary_10_1007_s12291_020_00898_2 crossref_primary_10_1002_jcb_28015 crossref_primary_10_1016_j_oooo_2013_10_018 crossref_primary_10_1159_000518521 crossref_primary_10_1111_odi_13640 crossref_primary_10_1002_dvdy_338 crossref_primary_10_1016_j_ajpath_2012_02_031 |
Cites_doi | 10.1093/jnci/dji011 10.1002/jcp.10072 10.1016/S0955-0674(97)80061-0 10.1002/jcp.20062 10.1677/erc.0.0070199 10.1016/j.ejso.2006.10.014 10.1242/dev.00859 10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0 10.3748/wjg.v16.i5.571 10.1016/j.exer.2007.01.019 10.1006/excr.2001.5195 10.1172/JCI17788 10.1038/sj.onc.1208918 10.1016/S0959-8049(00)00033-2 10.1111/j.1365-2559.2008.02971.x 10.1158/0008-5472.CAN-03-3888 10.1016/j.oraloncology.2008.06.002 10.1038/sj.cdd.4400368 10.1101/gad.13.22.2905 10.1186/1471-2407-9-315 10.1111/j.1349-7006.1991.tb01929.x 10.1002/jcp.10375 10.1002/path.2083 10.1038/sj.onc.1208417 10.1080/08977190410001723290 10.1006/excr.2000.4881 10.1016/S0168-9525(00)02006-0 10.1128/MCB.01168-06 |
ContentType | Journal Article |
Copyright | 2011 Elsevier Ltd Elsevier Ltd 2015 INIST-CNRS Copyright © 2011 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2011 Elsevier Ltd – notice: Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright © 2011 Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.oraloncology.2011.07.019 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Dentistry |
EISSN | 1879-0593 |
EndPage | 1031 |
ExternalDocumentID | 21824804 25527580 10_1016_j_oraloncology_2011_07_019 S1368837511007603 1_s2_0_S1368837511007603 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29N 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 8P~ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K X7M XPP Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c575t-5c288012fd3b3963f35e1005d4d361899f4bec5ce21adc76abe6c4de3f916c643 |
IEDL.DBID | .~1 |
ISSN | 1368-8375 1879-0593 |
IngestDate | Fri Sep 05 12:40:02 EDT 2025 Thu Apr 03 06:56:13 EDT 2025 Mon Jul 21 09:18:01 EDT 2025 Tue Jul 01 04:17:17 EDT 2025 Thu Apr 24 22:52:24 EDT 2025 Fri Feb 23 02:27:48 EST 2024 Sun Feb 23 10:19:38 EST 2025 Tue Aug 26 16:33:12 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Cell growth Oral squamous cell carcinoma Migration Cripto-1 Cell proliferation Cancerology Stomatology Oral cavity disease ENT Malignant tumor Cancer |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2011 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c575t-5c288012fd3b3963f35e1005d4d361899f4bec5ce21adc76abe6c4de3f916c643 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1016/j.oraloncology.2011.07.019 |
PMID | 21824804 |
PQID | 900629966 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_900629966 pubmed_primary_21824804 pascalfrancis_primary_25527580 crossref_primary_10_1016_j_oraloncology_2011_07_019 crossref_citationtrail_10_1016_j_oraloncology_2011_07_019 elsevier_sciencedirect_doi_10_1016_j_oraloncology_2011_07_019 elsevier_clinicalkeyesjournals_1_s2_0_S1368837511007603 elsevier_clinicalkey_doi_10_1016_j_oraloncology_2011_07_019 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-11-01 |
PublicationDateYYYYMMDD | 2011-11-01 |
PublicationDate_xml | – month: 11 year: 2011 text: 2011-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: England |
PublicationTitle | Oral oncology |
PublicationTitleAlternate | Oral Oncol |
PublicationYear | 2011 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Strizzi, Bianco, Hirota, Watanabe, Mancino, Hamada (b0150) 2007; 211 Wechselberger, Ebert, Bianco, Khan, Sun, Wallace-Jones (b0160) 2001; 266 Normanno, Bianco, Damiano, de Angelis, Selvam, Grassi (b0050) 1996; 2 Ebert, Wechselberger, Nees, Clair, Schaller, Martinez-Lacaci (b0155) 2000; 257 Adkins, Bianco, Schiffer, Rayhorn, Zafari, Cheung (b0025) 2003; 112 Bianco, Strizzi, Ebert, Chang, Rehman, Normanno (b0060) 2005; 97 Bianco, Strizzi, Rehman, Normanno, Wechselberger, Sun (b0030) 2003; 63 Bianco, Normanno, Salomon, Ciardiello (b0015) 2004; 22 Wu, Li, Wu, Weng, Li, Yao (b0075) 2009; 9 Wechselberger, Strizzi, Kenney, Hirota, Sun, Ebert (b0145) 2005; 24 Strizzi, Bianco, Normanno, Salomon (b0045) 2005; 24 Saeki, Stromberg, Qi, Gullick, Tahara, Normanno (b0085) 1992; 52 Hong, Lee, Park, Jeon, Bang, Park (b0125) 2009; 21 Warnakulasuriya (b0010) 2009; 45 Gray, Shani, Aung, Kelber, Vale (b0170) 2006; 26 Kuniyasu, Yoshida, Yokozaki, Yasui, Ito, Toge (b0080) 1991; 82 Normanno, De Luca, Bianco, Maiello, Carriero, Rehman (b0165) 2004; 198 Greene, Page, Fleming, Fritz, Balch, Haller (b0070) 2002 Robinson, Cobb (b0035) 1997; 9 Datta, Brunet, Greenberg (b0040) 1999; 13 Strizzi, Bianco, Normanno, Seno, Wechselberger, Wallace-Jones (b0065) 2004; 201 Shen, Schier (b0020) 2000; 16 . Saloman, Bianco, Ebert, Khan, De Santis, Normanno (b0100) 2000; 7 Niemeyer, Persico, Adamson (b0140) 1998; 5 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Mallikarjuna, Vaijayanthi, Krishnakumar (b0120) 2007; 84 Adamson, Minchiotti, Salomon (b0135) 2002; 190 Miyoshi, Ishii, Mimori, Sekimoto, Doki, Mori (b0130) 2010; 36 Gong, Yarrow, Carmalt, Kwun, Kennedy, Lin (b0105) 2007; 33 Morkel, Huelsken, Wakamiya, Ding, van de Wetering, Clevers (b0175) 2003; 130 Zhang, Zhao, Xin (b0095) 2010; 16 Panico, D’Antonio, Salvatore, Mezza, Tortora, De Laurentiis (b0090) 1996; 65 Zhong, Zhang, Jia, Shi, Niu, Du (b0115) 2008; 52 Ertoy, Ayhan, Saraç, Karaağaoğlu, Yasui, Tahara (b0110) 2000; 36 Xing, Hu, Pietersz, Hosick, McKenzie (b0055) 2004; 64 Shen (10.1016/j.oraloncology.2011.07.019_b0020) 2000; 16 Miyoshi (10.1016/j.oraloncology.2011.07.019_b0130) 2010; 36 Adamson (10.1016/j.oraloncology.2011.07.019_b0135) 2002; 190 Gray (10.1016/j.oraloncology.2011.07.019_b0170) 2006; 26 Datta (10.1016/j.oraloncology.2011.07.019_b0040) 1999; 13 Robinson (10.1016/j.oraloncology.2011.07.019_b0035) 1997; 9 Zhong (10.1016/j.oraloncology.2011.07.019_b0115) 2008; 52 Bianco (10.1016/j.oraloncology.2011.07.019_b0030) 2003; 63 Warnakulasuriya (10.1016/j.oraloncology.2011.07.019_b0010) 2009; 45 Normanno (10.1016/j.oraloncology.2011.07.019_b0165) 2004; 198 Strizzi (10.1016/j.oraloncology.2011.07.019_b0045) 2005; 24 Panico (10.1016/j.oraloncology.2011.07.019_b0090) 1996; 65 Ebert (10.1016/j.oraloncology.2011.07.019_b0155) 2000; 257 Kuniyasu (10.1016/j.oraloncology.2011.07.019_b0080) 1991; 82 Bianco (10.1016/j.oraloncology.2011.07.019_b0015) 2004; 22 Saloman (10.1016/j.oraloncology.2011.07.019_b0100) 2000; 7 Ertoy (10.1016/j.oraloncology.2011.07.019_b0110) 2000; 36 Wechselberger (10.1016/j.oraloncology.2011.07.019_b0145) 2005; 24 Niemeyer (10.1016/j.oraloncology.2011.07.019_b0140) 1998; 5 Hong (10.1016/j.oraloncology.2011.07.019_b0125) 2009; 21 Greene (10.1016/j.oraloncology.2011.07.019_b0070) 2002 Gong (10.1016/j.oraloncology.2011.07.019_b0105) 2007; 33 Zhang (10.1016/j.oraloncology.2011.07.019_b0095) 2010; 16 Mallikarjuna (10.1016/j.oraloncology.2011.07.019_b0120) 2007; 84 Strizzi (10.1016/j.oraloncology.2011.07.019_b0065) 2004; 201 Wu (10.1016/j.oraloncology.2011.07.019_b0075) 2009; 9 Strizzi (10.1016/j.oraloncology.2011.07.019_b0150) 2007; 211 Normanno (10.1016/j.oraloncology.2011.07.019_b0050) 1996; 2 Adkins (10.1016/j.oraloncology.2011.07.019_b0025) 2003; 112 Saeki (10.1016/j.oraloncology.2011.07.019_b0085) 1992; 52 Xing (10.1016/j.oraloncology.2011.07.019_b0055) 2004; 64 10.1016/j.oraloncology.2011.07.019_b0005 Wechselberger (10.1016/j.oraloncology.2011.07.019_b0160) 2001; 266 Bianco (10.1016/j.oraloncology.2011.07.019_b0060) 2005; 97 Morkel (10.1016/j.oraloncology.2011.07.019_b0175) 2003; 130 |
References_xml | – volume: 52 start-page: 3467 year: 1992 end-page: 3473 ident: b0085 article-title: Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors publication-title: Cancer Res – volume: 130 start-page: 6283 year: 2003 end-page: 6294 ident: b0175 article-title: Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation publication-title: Development – volume: 97 start-page: 132 year: 2005 end-page: 141 ident: b0060 article-title: Role of human cripto-1 in tumor angiogenesis publication-title: J Natl Cancer Inst – volume: 211 start-page: 36 year: 2007 end-page: 44 ident: b0150 article-title: Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice publication-title: J Pathol – volume: 9 start-page: 315 year: 2009 ident: b0075 article-title: Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma publication-title: BMC Cancer – volume: 36 start-page: 563 year: 2010 end-page: 568 ident: b0130 article-title: TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer publication-title: Int J Oncol – volume: 16 start-page: 303 year: 2000 end-page: 309 ident: b0020 article-title: The EGF–CFC gene family in vertebrate development publication-title: Trends Genet – volume: 2 start-page: 601 year: 1996 end-page: 609 ident: b0050 article-title: Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides publication-title: Clin Cancer Res – volume: 65 start-page: 51 year: 1996 end-page: 56 ident: b0090 article-title: Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues publication-title: Int J Cancer – volume: 190 start-page: 267 year: 2002 end-page: 278 ident: b0135 article-title: Cripto: a tumor growth factor and more publication-title: J Cell Physiol – volume: 64 start-page: 4018 year: 2004 end-page: 4023 ident: b0055 article-title: Cripto: a novel target for antibody-based cancer immunotherapy publication-title: Cancer Res – volume: 9 start-page: 180 year: 1997 end-page: 186 ident: b0035 article-title: Mitogen-activated protein kinase pathways publication-title: Curr Opin Cell Biol – volume: 26 start-page: 9268 year: 2006 end-page: 9278 ident: b0170 article-title: Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling publication-title: Mol Cell Biol – volume: 112 start-page: 575 year: 2003 end-page: 587 ident: b0025 article-title: Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo publication-title: J Clin Invest – volume: 257 start-page: 223 year: 2000 end-page: 229 ident: b0155 article-title: Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells publication-title: Exp Cell Res. – volume: 52 start-page: 560 year: 2008 end-page: 568 ident: b0115 article-title: Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer publication-title: Histopathology – volume: 21 start-page: 19 year: 2009 end-page: 24 ident: b0125 article-title: Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas publication-title: Oncol Rep – volume: 45 start-page: 309 year: 2009 end-page: 316 ident: b0010 article-title: Global epidemiology of oral and oropharyngeal cancer publication-title: Oral Oncol – volume: 16 start-page: 571 year: 2010 end-page: 577 ident: b0095 article-title: Significance and relationship between Cripto-1 and p-STAT3 expression in gastric cancer and precancerous lesions publication-title: World J Gastroenterol – volume: 84 start-page: 1060 year: 2007 end-page: 1066 ident: b0120 article-title: Cripto-1 expression in uveal melanoma: an immunohistochemical study publication-title: Exp Eye Res – volume: 63 start-page: 1192 year: 2003 end-page: 1197 ident: b0030 article-title: A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src publication-title: Cancer Res – volume: 198 start-page: 31 year: 2004 end-page: 39 ident: b0165 article-title: Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells publication-title: J Cell Physiol – volume: 13 start-page: 2905 year: 1999 end-page: 2927 ident: b0040 article-title: Cellular survival: a play in three Akts publication-title: Genes Dev – volume: 36 start-page: 1002 year: 2000 end-page: 1007 ident: b0110 article-title: Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas publication-title: Eur J Cancer – volume: 33 start-page: 438 year: 2007 end-page: 443 ident: b0105 article-title: Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival publication-title: Eur J Surg Oncol – volume: 7 start-page: 199 year: 2000 end-page: 226 ident: b0100 article-title: The EGF–CFC family: novel epidermal growth factor-related proteins in development and cancer publication-title: Endocr Relat Cancer – volume: 266 start-page: 95 year: 2001 end-page: 105 ident: b0160 article-title: Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells publication-title: Exp Cell Res – year: 2002 ident: b0070 article-title: AJCC cancer staging manual – volume: 201 start-page: 266 year: 2004 end-page: 276 ident: b0065 article-title: Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice publication-title: J Cell Physiol – volume: 24 start-page: 4094 year: 2005 end-page: 4105 ident: b0145 article-title: Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma publication-title: Oncogene – volume: 5 start-page: 440 year: 1998 end-page: 449 ident: b0140 article-title: Cripto: roles in mammary cell growth, survival, differentiation and transformation publication-title: Cell Death Differ – reference: Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. – volume: 24 start-page: 5731 year: 2005 end-page: 5741 ident: b0045 article-title: Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis publication-title: Oncogene – volume: 22 start-page: 133 year: 2004 end-page: 139 ident: b0015 article-title: Role of the cripto (EGF–CFC) family in embryogenesis and cancer publication-title: Growth Factors – reference: . – volume: 82 start-page: 969 year: 1991 end-page: 973 ident: b0080 article-title: Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas publication-title: Jpn J Cancer Res – volume: 36 start-page: 563 issue: 3 year: 2010 ident: 10.1016/j.oraloncology.2011.07.019_b0130 article-title: TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer publication-title: Int J Oncol – volume: 97 start-page: 132 issue: 2 year: 2005 ident: 10.1016/j.oraloncology.2011.07.019_b0060 article-title: Role of human cripto-1 in tumor angiogenesis publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dji011 – volume: 190 start-page: 267 issue: 3 year: 2002 ident: 10.1016/j.oraloncology.2011.07.019_b0135 article-title: Cripto: a tumor growth factor and more publication-title: J Cell Physiol doi: 10.1002/jcp.10072 – volume: 9 start-page: 180 issue: 2 year: 1997 ident: 10.1016/j.oraloncology.2011.07.019_b0035 article-title: Mitogen-activated protein kinase pathways publication-title: Curr Opin Cell Biol doi: 10.1016/S0955-0674(97)80061-0 – volume: 201 start-page: 266 issue: 2 year: 2004 ident: 10.1016/j.oraloncology.2011.07.019_b0065 article-title: Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice publication-title: J Cell Physiol doi: 10.1002/jcp.20062 – volume: 7 start-page: 199 issue: 4 year: 2000 ident: 10.1016/j.oraloncology.2011.07.019_b0100 article-title: The EGF–CFC family: novel epidermal growth factor-related proteins in development and cancer publication-title: Endocr Relat Cancer doi: 10.1677/erc.0.0070199 – volume: 33 start-page: 438 issue: 4 year: 2007 ident: 10.1016/j.oraloncology.2011.07.019_b0105 article-title: Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2006.10.014 – volume: 130 start-page: 6283 issue: 25 year: 2003 ident: 10.1016/j.oraloncology.2011.07.019_b0175 article-title: Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation publication-title: Development doi: 10.1242/dev.00859 – volume: 63 start-page: 1192 issue: 6 year: 2003 ident: 10.1016/j.oraloncology.2011.07.019_b0030 article-title: A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src publication-title: Cancer Res – volume: 65 start-page: 51 issue: 1 year: 1996 ident: 10.1016/j.oraloncology.2011.07.019_b0090 article-title: Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0 – volume: 16 start-page: 571 issue: 5 year: 2010 ident: 10.1016/j.oraloncology.2011.07.019_b0095 article-title: Significance and relationship between Cripto-1 and p-STAT3 expression in gastric cancer and precancerous lesions publication-title: World J Gastroenterol doi: 10.3748/wjg.v16.i5.571 – volume: 84 start-page: 1060 issue: 6 year: 2007 ident: 10.1016/j.oraloncology.2011.07.019_b0120 article-title: Cripto-1 expression in uveal melanoma: an immunohistochemical study publication-title: Exp Eye Res doi: 10.1016/j.exer.2007.01.019 – volume: 266 start-page: 95 issue: 1 year: 2001 ident: 10.1016/j.oraloncology.2011.07.019_b0160 article-title: Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells publication-title: Exp Cell Res doi: 10.1006/excr.2001.5195 – year: 2002 ident: 10.1016/j.oraloncology.2011.07.019_b0070 – volume: 112 start-page: 575 issue: 4 year: 2003 ident: 10.1016/j.oraloncology.2011.07.019_b0025 article-title: Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo publication-title: J Clin Invest doi: 10.1172/JCI17788 – volume: 24 start-page: 5731 issue: 37 year: 2005 ident: 10.1016/j.oraloncology.2011.07.019_b0045 article-title: Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis publication-title: Oncogene doi: 10.1038/sj.onc.1208918 – volume: 36 start-page: 1002 issue: 8 year: 2000 ident: 10.1016/j.oraloncology.2011.07.019_b0110 article-title: Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas publication-title: Eur J Cancer doi: 10.1016/S0959-8049(00)00033-2 – volume: 52 start-page: 560 issue: 5 year: 2008 ident: 10.1016/j.oraloncology.2011.07.019_b0115 article-title: Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer publication-title: Histopathology doi: 10.1111/j.1365-2559.2008.02971.x – volume: 64 start-page: 4018 issue: 11 year: 2004 ident: 10.1016/j.oraloncology.2011.07.019_b0055 article-title: Cripto: a novel target for antibody-based cancer immunotherapy publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-3888 – ident: 10.1016/j.oraloncology.2011.07.019_b0005 – volume: 21 start-page: 19 issue: 1 year: 2009 ident: 10.1016/j.oraloncology.2011.07.019_b0125 article-title: Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas publication-title: Oncol Rep – volume: 45 start-page: 309 issue: 4–5 year: 2009 ident: 10.1016/j.oraloncology.2011.07.019_b0010 article-title: Global epidemiology of oral and oropharyngeal cancer publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2008.06.002 – volume: 5 start-page: 440 issue: 5 year: 1998 ident: 10.1016/j.oraloncology.2011.07.019_b0140 article-title: Cripto: roles in mammary cell growth, survival, differentiation and transformation publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4400368 – volume: 13 start-page: 2905 issue: 22 year: 1999 ident: 10.1016/j.oraloncology.2011.07.019_b0040 article-title: Cellular survival: a play in three Akts publication-title: Genes Dev doi: 10.1101/gad.13.22.2905 – volume: 2 start-page: 601 issue: 3 year: 1996 ident: 10.1016/j.oraloncology.2011.07.019_b0050 article-title: Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides publication-title: Clin Cancer Res – volume: 52 start-page: 3467 issue: 12 year: 1992 ident: 10.1016/j.oraloncology.2011.07.019_b0085 article-title: Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors publication-title: Cancer Res – volume: 9 start-page: 315 year: 2009 ident: 10.1016/j.oraloncology.2011.07.019_b0075 article-title: Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma publication-title: BMC Cancer doi: 10.1186/1471-2407-9-315 – volume: 82 start-page: 969 issue: 9 year: 1991 ident: 10.1016/j.oraloncology.2011.07.019_b0080 article-title: Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas publication-title: Jpn J Cancer Res doi: 10.1111/j.1349-7006.1991.tb01929.x – volume: 198 start-page: 31 issue: 1 year: 2004 ident: 10.1016/j.oraloncology.2011.07.019_b0165 article-title: Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells publication-title: J Cell Physiol doi: 10.1002/jcp.10375 – volume: 211 start-page: 36 issue: 1 year: 2007 ident: 10.1016/j.oraloncology.2011.07.019_b0150 article-title: Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice publication-title: J Pathol doi: 10.1002/path.2083 – volume: 24 start-page: 4094 issue: 25 year: 2005 ident: 10.1016/j.oraloncology.2011.07.019_b0145 article-title: Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma publication-title: Oncogene doi: 10.1038/sj.onc.1208417 – volume: 22 start-page: 133 issue: 3 year: 2004 ident: 10.1016/j.oraloncology.2011.07.019_b0015 article-title: Role of the cripto (EGF–CFC) family in embryogenesis and cancer publication-title: Growth Factors doi: 10.1080/08977190410001723290 – volume: 257 start-page: 223 year: 2000 ident: 10.1016/j.oraloncology.2011.07.019_b0155 article-title: Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells publication-title: Exp Cell Res. doi: 10.1006/excr.2000.4881 – volume: 16 start-page: 303 issue: 7 year: 2000 ident: 10.1016/j.oraloncology.2011.07.019_b0020 article-title: The EGF–CFC gene family in vertebrate development publication-title: Trends Genet doi: 10.1016/S0168-9525(00)02006-0 – volume: 26 start-page: 9268 issue: 24 year: 2006 ident: 10.1016/j.oraloncology.2011.07.019_b0170 article-title: Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling publication-title: Mol Cell Biol doi: 10.1128/MCB.01168-06 |
SSID | ssj0005150 |
Score | 2.1522195 |
Snippet | Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due... Summary Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually,... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1023 |
SubjectTerms | Adult Aged Aged, 80 and over Biological and medical sciences Blotting, Western Carcinoma, Squamous Cell - genetics Carcinoma, Squamous Cell - metabolism Case-Control Studies Cell growth Cell Movement Cell Proliferation Cell Transformation, Neoplastic - genetics Cell Transformation, Neoplastic - metabolism Cripto-1 Epithelium - metabolism Female GPI-Linked Proteins - genetics GPI-Linked Proteins - metabolism Hematology, Oncology and Palliative Medicine Humans Immunohistochemistry Intercellular Signaling Peptides and Proteins - genetics Intercellular Signaling Peptides and Proteins - metabolism Male Medical sciences Middle Aged Migration Mouth Mucosa - metabolism Mouth Neoplasms - genetics Mouth Neoplasms - metabolism Neoplasm Proteins - genetics Neoplasm Proteins - metabolism Oral squamous cell carcinoma Otolaryngology Otorhinolaryngology. Stomatology Reverse Transcriptase Polymerase Chain Reaction Tumors Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology |
Title | The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1368837511007603 https://www.clinicalkey.es/playcontent/1-s2.0-S1368837511007603 https://dx.doi.org/10.1016/j.oraloncology.2011.07.019 https://www.ncbi.nlm.nih.gov/pubmed/21824804 https://www.proquest.com/docview/900629966 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1879-0593 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005150 issn: 1368-8375 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1879-0593 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005150 issn: 1368-8375 databaseCode: ACRLP dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1879-0593 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005150 issn: 1368-8375 databaseCode: AIKHN dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection 2013 customDbUrl: eissn: 1879-0593 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005150 issn: 1368-8375 databaseCode: .~1 dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-0593 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005150 issn: 1368-8375 databaseCode: AKRWK dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Na9RAFH-UCipI0fqVVpc5eE13k_lIFvFQtpZVaS9aqKdhZjIDW2yymt2DF_9235ska4sVFryGPDIz73vy3u8BvJkKn1e-KtNQepeKzIrUcmNR3V0eLPqIXFHv8Nm5ml-Ij5fycgdmQy8MlVX2tr-z6dFa90_G_WmOl4vF-HPGVYnplSTQs0JFxE9C_0KZPvp1o8wjk12nsCpTensAHo01XtQE39QRHvpnD-dZHEXUnbud1KOlafHoQjfz4t9BaXROp49hr48q2XG38Cew4-t9eHBClUA0zG0f7p_1_9CfwleUDEZFhawJbEY2o0kztqgZhoJstb6mUVlkABctM3XFYgFXB95BBLQX1n5fG7oyYHTtzxyNI6qba_MMLk7ff5nN037AQuowSlul0uUleahQcctREwOXHg9TVqLiKsNMLAhksXQ-z0zlCmWsV05UngcMKh3GMs9ht25q_xIYMpznRhUqYJpry2npM2-ss76QKnBeJDAdTlS7Hn2chmB800OZ2ZW-yQ1N3NCTQiM3EuAb2mWHwbEV1duBcXroMkW7qNFVbEVd3EXt217FW53pNtcT_ZcYJvBuQ3lLkrf-8uiWlG22nBNYniwnCbBB7DTaAuK0qT0yXU-pI5YS2ARedOL4hxjzSFFOxMF_ru4QHsZb9diN-Qp2Vz_W_jWGZSs7ino3gnvHHz7Nz38DmPs6xA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED9KCutgjK378j46PezVS2xZssPYQ8lW0rXJy1ronoQkS5Cy2mmdPOy_350tpyvrILBXw2H5vk---x3Ah3Hm0tKVRewLZ-MsMVlsuDZo7jb1BmNEKml2eDaX0_Ps24W42IFJPwtDbZXB93c-vfXW4ckwcHO4XCyG3xMuCyyvBIGe5ZIQP3czgT55ALuHxyfT-W2nRyK6YWFZxETQY4-2bV40B19XLUL0r4DomX9sgXfuj1OPlrpB7vlu7cW_89I2Ph09gcchsWSH3dmfwo6r9mHvCzUD0T63fXgwC7_Rn8EPVA5GfYWs9mxCbqOOE7aoGGaDbLW-om1Z5AMXDdNVydoerg6_gwjoW1hzvdZ0a8Do5p9Z2khU1Vf6OZwffT2bTOOwYyG2mKitYmHTgoKUL7nhaIyeC4f8FGVWcplgMeYzlLKwLk10aXOpjZM2Kx33mFdaTGdewKCqK_cKGMqcp1rm0mOla4px4RKnjTUuF9Jznkcw7jmqbAAgpz0YP1XfaXap_pSGImmoUa5QGhHwDe2yg-HYiupTLzjVD5qia1QYLbaizu-jdk2w8kYlqknVSP2liRF83lDeUeat33xwR8s2n5wSXp4oRhGwXu0UugOStK4cCl2NaSiWatgIXnbqeEuMpWRWjLLX_3m697A3PZudqtPj-ckbeNhesrfDmW9hsLpZu3eYpa3MQbDC3yXePW8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+Cripto-1+in+the+tumorigenesis+and+progression+of+oral+squamous+cell+carcinoma&rft.jtitle=Oral+oncology&rft.au=Yoon%2C+Hye-Jung&rft.au=Hong%2C+Ji-Soo&rft.au=Shin%2C+Wui-Jung&rft.au=Lee%2C+Yoo-Jin&rft.date=2011-11-01&rft.issn=1879-0593&rft.eissn=1879-0593&rft.volume=47&rft.issue=11&rft.spage=1023&rft_id=info:doi/10.1016%2Fj.oraloncology.2011.07.019&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F13688375%2FS1368837511X0012X%2Fcov150h.gif |